RB
Rohit Jaysing Bhor Bhor
Also known as: Bhor RJ
PRES's College of Pharmacy Pravaranagar, PRES's College of Pharmacy; Chincholi, Pravara Institute of Medical Sciences, MGV's College of Pharmacy; Panchavati Nashik
Employment
-
PRES's College of Pharmacy Pravaranagar Asst.Prof2017 - 2022
-
PRES's College of Pharmacy; Chincholi Asst. Prof2012 - 2017
Education
-
Pravara Institute of Medical Sciences Pharmaceutical Chemistry Ph.D2013 - 2020
-
MGV's College of Pharmacy; Panchavati Nashik M.Pharm2009 - 2011
-
MGV's College of Pharmacy Panchavati Nashik B.Pharm2005 - 2009
Projects & Funding
Projects & funding information is unavailable.
Publications (74)
- In Silico Screening and Molecular Dynamics Simulation of Tafenoquine Derivatives Targeting Plasmodium vivax Protease (PDB ID: 3IHZ) Save
- 3D-QSAR and Molecular Docking Studies of Antiarrhythmic Activity of Cardiac Sodium Channel (PDB: 8F6P) with Simulation Dynamic on a Series of Phenytoin Derivatives Save
- A Correlation of Molecular Docking and ADME Studies on 5,5-diphenylimidazolidine-2,4-dione: Inhibitors of Human Voltage-Gated Sodium Channel (Nav1.2)-2KAV Save
- Benzotriazole as Privileged Scaffold: A Molecular Docking Approach toward Breast Cancer Drug Discovery Save
- Exploring Neuroprotective Phytochemicals from Mucuna pruriens and Ginkgo biloba for Alzheimer’s Disease: A Molecular Docking and ADME Study Save
- In silico Design and Molecular Docking Evaluation of Phenothiazine Derivatives as Selective Celecoxib Bound to S121P Murine COX-2 Inhibitors for Targeted Therapy of Inflammatory Bowel Disease Save
- In silico Evaluation of Paroxysmal Neurological Disorders Using Molecular Docking Analysis of Hydantoin-Based Compounds Targeting Protein 1XBL for Anticonvulsant Activity Save
- Molecular Docking and ADMET Profiling of Hydantoin Derivatives Targeting Voltage-Gated Sodium Channel (PDB ID: 1N45) for Epilepsy Treatment Save
- In Silico Design and ADMET Profiling of Thiadiazole Derivatives Targeting NUDT5 (5NQR) for Breast Cancer Therapy Save
- In Silico Docking Study of Berberine Derivatives as AMPK Activators for Diabetes Mellitus via Multi-Target Protein Approach. Save